← Back to Search

ADEPT Program for Diagnostic Errors (ADEPT Trial)

N/A

Waitlist Available

Led By Andrew Auerbach

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult patients admitted to general medicine services at one of the participating hospitals and who either died during the hospitalization, were transferred to the ICU >= 48 hours after admission, or had a rapid response.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of the program (3 years)

Awards & highlights

ADEPT Trial Summary

This trial aims to reduce diagnostic errors in hospitals and develop sustainable approaches for the future with data sharing and collaboration.

Who is the study for?

This trial is for adult patients admitted to general medicine services at participating hospitals who either passed away during their stay, were moved to the ICU more than 48 hours after admission, or required rapid response intervention. It excludes those admitted for non-medical reasons or who were critically ill upon arrival.Check my eligibility

What is being tested?

The ADEPT Program aims to reduce diagnostic errors in hospitals by sharing data and collaborating on improving diagnostic processes. The program will develop sustainable methods within a learning health system model to enhance accuracy in diagnosing patient conditions.See study design

What are the potential side effects?

Since this study focuses on process improvement rather than medication or medical procedures, it does not have direct side effects like drugs do. However, there may be indirect impacts related to changes in hospital practices.

ADEPT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was admitted to a hospital, and either passed away, moved to ICU after 2 days, or had an emergency response.

ADEPT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of the program (3 years)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of the program (3 years)

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of the program (3 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diagnostic Errors

Secondary outcome measures

Diagnostic process faults

Harmful Diagnostic Errors

Other outcome measures

Adoption

Implementation

Maintenance

+1 more

ADEPT Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Patients admitted to study hospitals during the 36 months of the intervention

Group II: Pre-intervention (usual care)Active Control1 Intervention

Patients admitted to study hospitals in the 12 months prior to the start of the intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San FranciscoOTHER

2,505 Previous Clinical Trials

15,230,355 Total Patients Enrolled

Agency for Healthcare Research and Quality (AHRQ)FED

399 Previous Clinical Trials

6,815,148 Total Patients Enrolled

2 Trials studying Diagnostic Errors

511 Patients Enrolled for Diagnostic Errors

Brigham and Women's HospitalLead Sponsor

1,611 Previous Clinical Trials

11,463,319 Total Patients Enrolled

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05747755 — N/A

Diagnostic Errors Research Study Groups: Pre-intervention (usual care), Intervention

Diagnostic Errors Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05747755 — N/A

Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05747755 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment accepting new participants?

"As detailed on clinicaltrials.gov, this medical trial is not currently enrolling patients; the initiative having been first posted 3/1/2023 and last updated 2/17/2023. Nevertheless, there are two other trials open to potential participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Achieving Diagnostic Excellence Through Prevention and Teamwork

Jeffrey L. Schnipper, MD.,MPH. 2023. "Achieving Diagnostic Excellence Through Prevention and Teamwork". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05747755.